Outcome of the Board meeting interalia approved 1. Unaudited Financial Results ( consolidated and Standalone) along with Limited Review Report by the Statutory Auditors of the Company. 2. Re-appointment of Dr. Suresk Akella as Independent Director of the Company for the second consecutive term w.e.f 30.09.2026, subject to the shareholders Approval3. other Items as mentioned in detailed in attachment -a/a